Home »
Academic Articles & Research Papers
Showing 20 of 105 academic articles
Vroemen WHM, Dragon-Durey MA, Allenbach Y, Berki T et al. • Journal of translational autoimmunity
(2026)
PMC
PMC Public Access (View-Only)
DOI: 10.1016/j.jtauto.2026.100398
PMC: PMC13571532
Ionitescu RC • Frontiers in immunology
(2026)
PMC
PMC Public Access (View-Only)
DOI: 10.3389/fimmu.2026.1848870
PMC: PMC13582633
Sereme Y, Villeret B, Caboche S, Ikeh S et al. • Molecular therapy : the journal of the American Society of Gene Therapy
(2026)
PMC
PMC Public Access (View-Only)
DOI: 10.1016/j.ymthe.2026.06.029
PMC: PMC13555540
Zanvit P, Xu J, Yang W, Guo N et al. • Barrier immunity
(2026)
PMC
PMC Public Access (View-Only)
DOI: 10.1002/dni2.70003
PMC: PMC13618908
Sanz-Muñoz I, Ciria-Gil CJ, Hernandez M, Santiago C et al. • The Journal of infection
(2026)
PMC
PMC Public Access (View-Only)
DOI: 10.1016/j.jinf.2026.106822
PMC: PMC13619460
Vishwakarma A, Patil A, Saini D, Shankar A et al. • Frontiers in immunology
(2026)
PMC
PMC Public Access (View-Only)
DOI: 10.3389/fimmu.2026.1913744
PMC: PMC13619387
Tang M, Li J, Zhang C, Tu R et al. • Frontiers in aging neuroscience
(2026)
PMC
PMC Public Access (View-Only)
DOI: 10.3389/fnagi.2026.1973833
PMC: PMC13643708
Yang W, Yu T, Cong Y • Barrier immunity
(2026)
PMC
PMC Public Access (View-Only)
DOI: 10.1002/dni2.70017
PMC: PMC13681326
Sun S, Ma L • Frontiers in immunology
(2026)
PMC
PMC Public Access (View-Only)
DOI: 10.3389/fimmu.2026.1782124
PMC: PMC13682303
Wang R, Hu H, Chen Y, Yang W et al. • hLife
(2026)
PMC
PMC Public Access (View-Only)
DOI: 10.1016/j.hlife.2025.11.001
PMC: PMC13681588
do Nascimento MI, Valente Junior AT, de Vasconcelos Falcão B, da Silva MP et al. • Journal of family & reproductive health
(2026)
PMC
PMC Public Access (View-Only)
DOI: 10.18502/jfrh.v20i2.22614
PMC: PMC13690109
Guo B, Wang J, Zhao R, Li S et al. • Antioxidants (Basel, Switzerland)
(2026)
PMC
PMC Public Access (View-Only)
DOI: 10.3390/antiox15101314
PMC: PMC13701681
Negi S, Hashimoto-Hill S, Waddell A, Engleman L et al. • Science translational medicine
(2026)
PMC
PMC Public Access (View-Only)
DOI: 10.1126/scitranslmed.adx6147
PMC: PMC13712116
Mørk N, Jensen JA, Bastard P, Larsen LA et al. • Journal of human immunity
(2027)
PMC
PMC Public Access (View-Only)
DOI: 10.70962/jhi.20260143
PMC: PMC13712330
Li K, Qian Z, Zhang J, Mao J et al. • Frontiers in immunology
(2026)
PMC
PMC Public Access (View-Only)
DOI: 10.3389/fimmu.2026.1901272
PMC: PMC13714599
Kepu Zheng, Leiyang Dai, Yanghui Wen, Haitao Jiang et al. • Annals of Medicine
(2026)
Background Macrophages are central regulators of liver immunity and fibrosis; Recent single-cell studies have characterized macrophage heterogeneity in cirrhosis; however, how regulated cell death programs shape their functional transitions...
DOAJ
Open Access (DOAJ)
DOI: 10.1080/07853890.2026.2690717
Katja Niesel, Michael Schulz, Julian Anthes, Tijna Alekseeva et al. • EMBO Molecular Medicine
(2021)
Abstract The tumor microenvironment in brain metastases is characterized by high myeloid cell content associated with immune suppressive and cancer‐permissive functions. Moreover, brain metastases induce the recruitment of lymphocytes. Desp...
DOAJ
Open Access (DOAJ)
DOI: 10.15252/emmm.202013412
Bo Cai, Shixue Chang, Yuhan Tian, Shuai Zhen • Immunity, Inflammation and Disease
(2023)
Abstract Hepatitis B virus (HBV) infection remains a global health challenge. Despite the availability of effective preventive vaccines, millions of people are at risk of cirrhosis and hepatocellular carcinoma. Current drug therapies inhibi...
DOAJ
Open Access (DOAJ)
DOI: 10.1002/iid3.866
Benjamin A. Pierce (2002)
Introduction to Genetics Genetics Is Important to Us Individually, to Society, and to the Study of Biology Humans Have Been Using Genetics for Thousands of Years A Few Fundamental Concepts Are Important for the Start of Our Journey into Gen...
OPENALEX
Haiting Jiang, Chengyu Wei • Frontiers in Public Health
(2024)
China, with the severe burden of hepatitis B, plays a significant role in the global efforts towards eliminating hepatitis B disease by 2030. Vaccination is recognized as the most effective measure to prevent infectious diseases. However, v...
DOAJ
Open Access (DOAJ)
DOI: 10.3389/fpubh.2024.1286801